Cost considerations as potential barriers to cancer treatment

Cancer Practice

Volumn 6, Issue 3, 1998, Pages 182-187

  Guidry, Jeffrey J ^a   Aday, Lu Ann ^b   Zhang, Dong ^c   Winn, Rodger J ^d  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Chemotherapy; Cost; Radiotherapy; Treatment barriers

Indexed keywords

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; COST EFFECTIVENESS ANALYSIS; DRUG COST; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH INSURANCE; HEALTH MAINTENANCE ORGANIZATION; HOSPITAL COST; MEDICAL FEE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; CONTINENTAL POPULATION GROUPS; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; FINANCING, PERSONAL; HEALTH SERVICES ACCESSIBILITY; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; NEOPLASMS; QUESTIONNAIRES; SOCIAL CLASS; TEXAS;

EID: 0031958401     PISSN: 10654704     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-5394.1998.006003182.x     Document Type: Article

References (18)

1. Anderson G, Steinbery EP, Wittly J, Powe NR, Antebi S, Herbert R. Development of clinical and economic prognoses from Medicare claims data. JAMA 1990; 263:967-972.
2. Gaumer GL, Stavins J. Medicare use in the last 90 days of life. Health Serv Res 1992; 26:725-742.
3. Hoffman C, Rice D, Sung H. Persons with chronic conditions. JAMA 1996; 276(18):1473-1479.
4. Weissman JS, Stern R, Fielding SL, Epstein AM. Delayed access to health care: risk factors, reasons, and consequences. Ann Intern Med 1991; 114:325-31.
5. Rice DP, Hodgson TA, Capell F. The economic burden of cancer, 1985: United States and California. In: Schiffler RM, Andrews NC, eds. Cancer Care and Cost. Ann Arbor, Mich: Health Administration Press Perspectives; 1989.
6. American Cancer Society. Cancer Facts and Figures - 1997. Atlanta, Ga, 1997.
7. Mechanic D. Social research in health and the American sociopolitical context: The changing fortunes of medical sociology. Soc Sci Med 1993; 36(2):95-102.
8. Russell LB, Chaudhuri A. The inequality of medical expenditures for several years in a healthy, nonelderly population. Med Care 1992; 30(10):908-916.
9. Wagner EH, Bledsoe T. The RAND Health Insurance Experiment and HMOs. Med Care 1990; 28(3): 191-200.
10. Anderson JL. Insurability of cancer patients. Oncol Nurs Forum 1984; 11:42-45.
11. Burstin HR, Lipsitz SR, Brennan TA. Socioeconomic status and risk for substandard medical care. JAMA 1992; 268: 2383-2387.
12. Weissman J, Epstein AM. Case mix and resource utilization by uninsured hospital patients in the Boston metropolitan area. JAMA 1989; 261:3572-3576.
13. Yergan J, Flood AB, Diehr P, LoGerfo JP. Relationship between patient source of payment and the intensity of hospital services. Med Care 1988; 26:111-114.
14. Diehr P, Yergan J, Chu J, et al. Treatment modality and quality differences for Black and White breast-cancer patients treated in community hospitals. Med Care 1989; 27:942-958.
15. Greenberg ER, Chute CG, Stukel T, et al. Social and economic factors in the choice of lung cancer treatment. N Engl J Med 1988; 318(10):612-617.
16. Morgan MA, Behbakht K, Benjamin I, Berlin M, King SA, Rubin SC. Racial differences in survival from gynecologic cancer. Obstet Gynecol 1996; 88(6):914-918.
17. Weissman JS, Makadon HJ, Seage GR, et al. Changes in insurance status and access to care for persons with AIDS in the Boston health study. Am J Public Health 1994; 84(12): 1997-2000.
18. Dillman DA. Mail and Telephone Surveys: The Total Design Method. New York: Wiley, 1978.